SPP1 and coronary artery disorder: While emerging data suggest a correlation between elevated OPN and proxy measures of coronary ischemia, like the increased severity of CAD [16], there is limited evidence to show that changes in clinical status are reflected by changes in plasma OPN levels [54]—an accurate measure of a biomarker’s utility as a surrogate for disease.